SOPHiA Genetics SASOPH
Price$8.03Intrinsic value$5.2335% below price

Financial Snapshot

Revenue, profitability, returns, debt, and capital allocation

Revenue $81.2M+22.0% YoYTTM through 31 Dec 2025
Net Income -$79MTTM through 31 Dec 2025
Free Cash Flow -$36.5MTTM through 31 Dec 2025

Margins

Current
Gross Margin68.0%
EBITDA Margin-82.4%
Operating Margin-79.7%
Net Margin-89.1%

Returns

-177.2%ROE
-29.7%ROA

Balance Sheet Health

Debt / Equity1.05x
Current Ratio1.96x
Net Debt-$17.5Mnet cash position
Cash & Equivalents$70.3M

Quality Metrics

Piotroski F-Score1 / 9
FCF Margin-44.9%
Rule of 40-29.9
Earnings-Beat Rate75.0%

Multi-Year Trend

Diluted EPS
'20'21'22'23'24'25
FY2025: $-1.17

Dividend

No dividend

Capital Allocation

Capex Intensity2.6%
All values are periodic snapshots, not live quotes. Source dates are shown for reference.

Filing Detail Members

This section is available to registered members. Create a free account or sign in to unlock the full breakdown.

Sign in / Sign up
AI-assisted, source-linked narrative; figures from company filings (SEC EDGAR) and market data. Dates shown per section. Not investment advice. Terms of Use.